These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34622103)

  • 1. The variety of genetic defects explains the phenotypic heterogeneity of Familial Hyperkalemic Hypertension.
    Hureaux M; Mazurkiewicz S; Boccio V; Vargas-Poussou R; Jeunemaitre X
    Kidney Int Rep; 2021 Oct; 6(10):2639-2652. PubMed ID: 34622103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation affecting the conserved acidic WNK1 motif causes inherited hyperkalemic hyperchloremic acidosis.
    Louis-Dit-Picard H; Kouranti I; Rafael C; Loisel-Ferreira I; Chavez-Canales M; Abdel-Khalek W; Argaiz ER; Baron S; Vacle S; Migeon T; Coleman R; Do Cruzeiro M; Hureaux M; Thurairajasingam N; Decramer S; Girerd X; O'Shaugnessy K; Mulatero P; Roussey G; Tack I; Unwin R; Vargas-Poussou R; Staub O; Grimm R; Welling PA; Gamba G; Clauser E; Hadchouel J; Jeunemaitre X
    J Clin Invest; 2020 Dec; 130(12):6379-6394. PubMed ID: 32790646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Homozygous KLHL3 Mutation as a Cause of Autosomal Recessive Pseudohypoaldosteronism Type II Diagnosed Late in Life.
    Etges A; Hellmig N; Walenda G; Haddad BG; Machtens JP; Morosan T; Rump LC; Scholl UI
    Nephron; 2022; 146(4):418-428. PubMed ID: 35093948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Spanish Family with Gordon Syndrome Due to a Variant in the Acidic Motif of
    Peces R; Peces C; Espinosa L; Mena R; Blanco C; Tenorio-Castaño J; Lapunzina P; Nevado J
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
    Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
    Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel
    Chatrathi HE; Collins JC; Wolfe LA; Markello TC; Adams DR; Gahl WA; Werner A; Sharma P
    Hypertension; 2022 Jan; 79(1):60-75. PubMed ID: 34878901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Hyperkalemia and Hypertension (FHHt) and KLHL3: Description of a Family with a New Recessive Mutation (S553L) Compared to a Family with a Dominant Mutation, Q309R, with Analysis of Urinary Sodium Chloride Cotransporter.
    Kliuk-Ben Bassat O; Carmon V; Hanukoglu A; Ganon L; Massalha E; Holtzman EJ; Farfel Z; Mayan H
    Nephron; 2017; 137(1):77-84. PubMed ID: 28511177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome).
    Glover M; Ware JS; Henry A; Wolley M; Walsh R; Wain LV; Xu S; Van't Hoff WG; Tobin MD; Hall IP; Cook S; Gordon RD; Stowasser M; O'Shaughnessy KM
    Clin Sci (Lond); 2014 May; 126(10):721-6. PubMed ID: 24266877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
    Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
    Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal COP9 Signalosome Deficiency Alters CUL3-KLHL3-WNK Signaling Pathway.
    Cornelius RJ; Si J; Cuevas CA; Nelson JW; Gratreak BDK; Pardi R; Yang CL; Ellison DH
    J Am Soc Nephrol; 2018 Nov; 29(11):2627-2640. PubMed ID: 30301860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.
    Boyden LM; Choi M; Choate KA; Nelson-Williams CJ; Farhi A; Toka HR; Tikhonova IR; Bjornson R; Mane SM; Colussi G; Lebel M; Gordon RD; Semmekrot BA; Poujol A; Välimäki MJ; De Ferrari ME; Sanjad SA; Gutkin M; Karet FE; Tucci JR; Stockigt JR; Keppler-Noreuil KM; Porter CC; Anand SK; Whiteford ML; Davis ID; Dewar SB; Bettinelli A; Fadrowski JJ; Belsha CW; Hunley TE; Nelson RD; Trachtman H; Cole TR; Pinsk M; Bockenhauer D; Shenoy M; Vaidyanathan P; Foreman JW; Rasoulpour M; Thameem F; Al-Shahrouri HZ; Radhakrishnan J; Gharavi AG; Goilav B; Lifton RP
    Nature; 2012 Jan; 482(7383):98-102. PubMed ID: 22266938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Arterial Hypertension from Cullin 3 Mutations Is Caused by Both Renal and Vascular Effects.
    Abdel Khalek W; Rafael C; Loisel-Ferreira I; Kouranti I; Clauser E; Hadchouel J; Jeunemaitre X
    J Am Soc Nephrol; 2019 May; 30(5):811-823. PubMed ID: 30967423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation by Cullin 3 and effect on WNK kinases suggest a role of KLHL2 in the pathogenesis of Familial Hyperkalemic Hypertension.
    Zhang C; Meermeier NP; Terker AS; Blankenstein KI; Singer JD; Hadchouel J; Ellison DH; Yang CL
    Biochem Biophys Res Commun; 2016 Jan; 469(1):44-48. PubMed ID: 26607111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROMK expression remains unaltered in a mouse model of familial hyperkalemic hypertension caused by the CUL3Δ403-459 mutation.
    Murthy M; Kurz T; O'Shaughnessy KM
    Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27378813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and biochemical characterization of the KLHL3-WNK kinase interaction important in blood pressure regulation.
    Schumacher FR; Sorrell FJ; Alessi DR; Bullock AN; Kurz T
    Biochem J; 2014 Jun; 460(2):237-46. PubMed ID: 24641320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WNK1-related Familial Hyperkalemic Hypertension results from an increased expression of L-WNK1 specifically in the distal nephron.
    Vidal-Petiot E; Elvira-Matelot E; Mutig K; Soukaseum C; Baudrie V; Wu S; Cheval L; Huc E; Cambillau M; Bachmann S; Doucet A; Jeunemaitre X; Hadchouel J
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14366-71. PubMed ID: 23940364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel KLHL3-interacting motif in the C-terminal region of WNK4.
    Wang L; Wu G; Peng JB
    Biochem Biophys Res Commun; 2023 Aug; 670():87-93. PubMed ID: 37285722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and analysis of a mouse model of pseudohypoaldosteronism type II caused by KLHL3 mutation in BTB domain.
    Lin CM; Cheng CJ; Yang SS; Tseng MH; Yen MT; Sung CC; Lin SH
    FASEB J; 2019 Jan; 33(1):1051-1061. PubMed ID: 30148674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron.
    Louis-Dit-Picard H; Barc J; Trujillano D; Miserey-Lenkei S; Bouatia-Naji N; Pylypenko O; Beaurain G; Bonnefond A; Sand O; Simian C; Vidal-Petiot E; Soukaseum C; Mandet C; Broux F; Chabre O; Delahousse M; Esnault V; Fiquet B; Houillier P; Bagnis CI; Koenig J; Konrad M; Landais P; Mourani C; Niaudet P; Probst V; Thauvin C; Unwin RJ; Soroka SD; Ehret G; Ossowski S; Caulfield M; ; Bruneval P; Estivill X; Froguel P; Hadchouel J; Schott JJ; Jeunemaitre X
    Nat Genet; 2012 Mar; 44(4):456-60, S1-3. PubMed ID: 22406640
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.